Literature DB >> 21105876

Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington's disease.

Chiara Soldati1, Angela Bithell, Paola Conforti, Elena Cattaneo, Noel J Buckley.   

Abstract

Transcriptional dysfunction is a prominent hallmark of Huntington's disease (HD). Several transcription factors have been implicated in the aetiology of HD progression and one of the most prominent is repressor element 1 (RE1) silencing transcription factor (REST). REST is a global repressor of neuronal gene expression and in the presence of mutant Huntingtin increased nuclear REST levels lead to elevated RE1 occupancy and a concomitant increase in target gene repression, including brain-derived neurotrophic factor. It is of great interest to devise strategies to reverse transcriptional dysregulation caused by increased nuclear REST and determine the consequences in HD. Thus far, such strategies have involved RNAi or mutant REST constructs. Decoys are double-stranded oligodeoxynucleotides corresponding to the DNA-binding element of a transcription factor and act to sequester it, thereby abrogating its transcriptional activity. Here, we report the use of a novel decoy strategy to rescue REST target gene expression in a cellular model of HD. We show that delivery of the decoy in cells expressing mutant Huntingtin leads to its specific interaction with REST, a reduction in REST occupancy of RE1s and rescue of target gene expression, including Bdnf. These data point to an alternative strategy for rebalancing the transcriptional dysregulation in HD.
© 2010 The Authors. Journal of Neurochemistry © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21105876     DOI: 10.1111/j.1471-4159.2010.07122.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

1.  Regulation of neural gene transcription by optogenetic inhibition of the RE1-silencing transcription factor.

Authors:  Francesco Paonessa; Stefania Criscuolo; Silvio Sacchetti; Davide Amoroso; Helena Scarongella; Federico Pecoraro Bisogni; Emanuele Carminati; Giacomo Pruzzo; Luca Maragliano; Fabrizia Cesca; Fabio Benfenati
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-23       Impact factor: 11.205

2.  Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotides.

Authors:  Osamu Nakagawa; Xin Ming; Kyle Carver; Rudy Juliano
Journal:  Bioconjug Chem       Date:  2013-12-19       Impact factor: 4.774

Review 3.  Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides.

Authors:  Rudolph L Juliano; Xin Ming; Osamu Nakagawa
Journal:  Bioconjug Chem       Date:  2011-10-27       Impact factor: 4.774

Review 4.  NRSF: an angel or a devil in neurogenesis and neurological diseases.

Authors:  Zhiqi Song; Deming Zhao; Huajia Zhao; Lifeng Yang
Journal:  J Mol Neurosci       Date:  2014-12-06       Impact factor: 3.444

5.  REST/NRSF drives homeostatic plasticity of inhibitory synapses in a target-dependent fashion.

Authors:  Cosimo Prestigio; Daniele Ferrante; Antonella Marte; Alessandra Romei; Gabriele Lignani; Franco Onofri; Pierluigi Valente; Fabio Benfenati; Pietro Baldelli
Journal:  Elife       Date:  2021-12-02       Impact factor: 8.140

Review 6.  Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis.

Authors:  Amit Kumar; Manisha Vaish; Rajiv R Ratan
Journal:  Drug Discov Today       Date:  2014-03-21       Impact factor: 7.851

Review 7.  Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for Duchenne muscular dystrophy.

Authors:  Maria Sofia Falzarano; Chiara Passarelli; Alessandra Ferlini
Journal:  Nucleic Acid Ther       Date:  2014-02       Impact factor: 5.486

8.  Nucleic Acid-Based Therapy Approaches for Huntington's Disease.

Authors:  Tatyana Vagner; Deborah Young; Alexandre Mouravlev
Journal:  Neurol Res Int       Date:  2012-01-11

Review 9.  The Transcription Repressor REST in Adult Neurons: Physiology, Pathology, and Diseases

Authors:  Pietro Baldelli; Jacopo Meldolesi
Journal:  eNeuro       Date:  2015-07-10

10.  HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic pain.

Authors:  Franziska Denk; Wenlong Huang; Ben Sidders; Angela Bithell; Megan Crow; John Grist; Simone Sharma; Daniel Ziemek; Andrew S C Rice; Noel J Buckley; Stephen B McMahon
Journal:  Pain       Date:  2013-05-18       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.